HOME › DRUGS › RECOMBINANT HUMAN C1 INHIBITOR
ACTIVE SUBSTANCE / INN

RECOMBINANT HUMAN C1 INHIBITOR

Brand name(s): Rhucin
EMA LISTED
REFUSED
Angioedema
ACTIVE SUBSTANCE
Recombinant Human C1 Inhibitor
REGULATORS
EMA
SPONSORS / MAH
Pharming Group N.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RhucinPharming Group N.V.RefusedAngioedema

FULL INTELLIGENCE ON RECOMBINANT HUMAN C1 INHIBITOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →